News

Global Anti-Snoring Devices Market to Reach $1.45 Billion by 2029

Global Anti-Snoring Devices Market to Reach $1.45 Billion by 2029

The Growing Anti-Snoring Devices Market

The global anti-snoring devices market, currently valued at approximately US$ 0.83 billion, is on a promising trajectory with expectations to grow significantly. Forecasts indicate that by 2024, the market will reach about US$ 0.91 billion, eventually hitting an impressive US$ 1.45 billion by 2029. This growth is set against a backdrop of increasing health awareness and technological advancements aimed at tackling the challenges associated with sleep disorders.

Key Drivers of Growth

Several factors are driving the expansion of the anti-snoring devices market. A primary contributor is the rising incidence of sleep disorders, particularly sleep apnea, affecting a significant portion of the population. As society becomes more health-conscious, there is a growing understanding of the implications of untreated sleep apnea, leading to increased demand for effective solutions.

Technological innovations in treatment options are another key driver. With enhanced features promoting patient compliance, newer devices are being developed to ensure that individuals have better experiences while using these products. Moreover, the aging population, alongside increasing rates of obesity and lifestyle choices, including alcohol and tobacco consumption, further intensifies the need for effective anti-snoring solutions.

Segments of the Market

Device Types

Within the anti-snoring devices market, the oral appliances segment is witnessing the fastest growth. This category, which includes mandibular advancement devices (MADs) and tongue-retaining devices (TRDs), holds a large portion of the market share. More healthcare providers and patients are recognizing the cost-effectiveness and accessibility of oral appliances over other solutions, driving up their adoption and use.

Market by Gender

The market is also segmented by gender, confirming that male patients account for a larger share. This trend can be attributed to physiological differences that predispose males to higher risks of obstructive sleep apnea (OSA) and snoring. Such insights are pivotal for targeted marketing strategies and product development.

Distribution Channels

Emerging Trends

In terms of distribution channels, retail pharmacies captured the largest share recently, driven by factors such as convenience and affordability. The rise of online pharmacies has also democratized access to anti-snoring devices, allowing consumers to acquire these products easily without the need for face-to-face consultations.

Adaptation of Technology

The anti-snoring devices market shows promise through multiple avenues of adaptation and technology. The evolution of home care settings has played a crucial role in market gains, as more patients are opting for home sleep test kits and devices designed for home use. This reflects a shift toward more personalized healthcare solutions that cater to individual patient needs.

Geographical Insights

Regionally, North America leads the global market, propelled by a high prevalence of sleep apnea among its population. The increasing demand for alternatives to traditional treatment options such as CPAP therapies is fostering market growth in this region. Notably, the Asia Pacific region is projected to experience the highest growth rate due to rising health awareness, improving healthcare facilities, and a large population that remains undiagnosed.

Leading Market Players

Prominent companies in this field include ResMed and SomnoMed, which have carved out substantial market shares. ResMed, for instance, reported significant revenue from its sleep and respiratory care segments, reflecting a strong operation within this space. SomnoMed focuses extensively on expanding into new markets and advancing product offerings, demonstrating the competitive and innovative nature of this industry.

Frequently Asked Questions

What is the expected growth of the anti-snoring devices market?

The anti-snoring devices market is forecasted to reach USD 1.45 billion by 2029, growing at a CAGR of 9.8%.

Which segments are driving this market's growth?

The oral appliances segment is the fastest-growing, with a significant boost from increasing awareness and demand among healthcare providers and patients.

How does gender affect the anti-snoring devices market?

Male patients represent a larger share due to physiological differences that increase the risks associated with sleep apnea and snoring.

What distribution channels are popular for these devices?

Retail pharmacies dominate the market due to their convenience, although online platforms are gaining popularity for purchasing anti-snoring devices.

Who are the key players in the anti-snoring devices market?

Major players include ResMed and SomnoMed, recognized for their innovations and substantial market share in this sector.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 146

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 72

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
EZaccessMD Data Breach: Class Action Lawsuit Looms

Updated Category News Views 626

Data breaches are the bogeyman no one wants lurking in the shadows, and when it’s your personal info at stake, folks rightfully squirm. This recent fiasco at EZaccessMD is one of those unsettling incidents. The word on the street isn't pretty: sensitive medical data has slipped through the cracks, leaving Edelson Lechtzin LLP, a heavyweight in class action maneuvers, to...

Continue Reading
Championing Change: USTA Mid-Atlantic Gala's Impact

Updated Category News Views 168

A Night to Remember: USTA Mid-Atlantic's Gala Who would've thought tennis could wield such transformative power? This ain't your average sport gala. Last Saturday, a crowd of over 300 gathered at the Ritz-Carlton Tysons Corner for the USTA Mid-Atlantic Foundation's 2026 Tennis Creates Gala. Hosted by the formidable Malika Andrews, this event wasn't just a fancy...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 189

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 334

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 42

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
Princess Cruises Launches New Era at Celebration Key

Updated Category News Views 92

Never thought I'd see the day when a cruise ship docking would stir such excitement, but here we are. The Star Princess has made its grand debut at Celebration Key, the latest jewel in Princess Cruises' crown. And they're going all out with Bahamian flair—something about a Junkanoo band and beach art that would make even the crustiest sailor crack a smile. Inaugural Fun...

Continue Reading
Shenzhen's Vision Unveiled: APEC 2026 Promo Debut

Updated Category News Views 356

Shenzhen's Spotlight Moment at APEC 2026 When Shenzhen announced its promotional video for the 2026 APEC Economic Leaders' Meeting, it wasn't just about standard tourism glitz. This was a show of force, a bold step onto the main stage of global politics and economics. The video's launch wasn’t merely an audio-visual delight—it staked a claim in shaping the future...

Continue Reading
Servier's Data on Tovorafenib Shows Promise in pLGG

Updated Category News Views 570

New Light on a Critical Challenge Talk about a fight in the dark. Pediatric low-grade glioma (pLGG) is a menace that families dread, an uphill battle with odds that feel relentless. Enter Servier and its four-year updated data on OJEMDA® (tovorafenib), a beacon of hope for kids battling these tricky brain tumors. Results, presented at the SNO meeting, are fresh off the...

Continue Reading

Top 5 Most Recently Viewed Articles

Jade Power Trust Celebrates Success at Annual and Special Meeting

Updated Category News Views 190

Jade Power Trust's Annual Meeting Highlights Jade Power Trust (TSXV: JPWR.H) recently concluded its Annual and Special Meeting of unitholders, where significant decisions were made to shape the future of the Trust. The meeting, organized with great attention and resources, took place with a focus on transparency and community engagement. Re-election of Board Members...

Continue Reading
Vesper Bio's Breakthrough Phase I Results for FTD Treatment

Updated Category News Views 112

Vesper Bio Reports Positive Results from Phase I Study Vesper Bio ApS, a biotech company in the clinical stage known for its advancements in sortilin receptor biology, has made significant strides with its lead candidate, VES001. This groundbreaking compound is emerging as a potentially disease-modifying treatment for patients diagnosed with frontotemporal dementia (FTD),...

Continue Reading
Texas Pacific Land Trust Achieves Record Stock Performance

Updated Category News Views 103

Texas Pacific Land Trust Reaches New Heights In a significant display of market strength, Texas Pacific Land Trust (NYSE: TPL) stock has soared to an extraordinary all-time high of $996.82. This remarkable feat highlights a period of impressive growth for the company, as its stock has demonstrated a stunning 63.04% increase over the past year. Investors are exhibiting...

Continue Reading
Headwall Photonics Partners with NV5 to Enhance ENVI Software

Updated Category News Views 77

Headwall Photonics scored a major win back in 2024, announcing a strategic partnership with NV5 that aimed to shake up the hyperspectral imaging landscape. The deal wasn’t just about another tech tie-up; it was about embedding NV5's renowned ENVI software into Headwall's offerings, which could change how users handle geospatial data. ENVI Software Integration: What’s...

Continue Reading
DZS Inc. Completes Strategic Asset Sale to AXON Networks

Updated Category News Views 222

DZS Inc. Completes Strategic Asset Sale DZS Inc. (OTC: DZSI), known for its advanced network edge, connectivity, and cloud edge software solutions, has successfully completed the sale of its service assurance and WiFi management software portfolio to AXON Networks. This transaction includes key products such as Expresse, CloudCheck, and TruSpeed, along with their...

Continue Reading